Scientists are reporting development and successful lab tests on the first potential drug to pack a lethal one-two punch against melanoma skin cancer cells. Hit number one destroys cells in the main tumor, ...
Jun 05, 2013
5 / 5 (4)
0
The journal Accounts of Chemical Research has published the article "Anion Transporters and Biological Systems", by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therap ...
Apr 19, 2013
not rated yet
0
Scientists at Washington University School of Medicine in St. Louis and elsewhere have decoded the genome of the platyfish, a cousin of the guppy and a popular choice for home aquariums. Among scientists, ...
Apr 15, 2013
5 / 5 (1)
1
|
(Phys.org)—Malignant melanoma is the most aggressive type of skin cancer. In more than 50 percent of affected patients a particular mutation plays an important role. As the life span of the patients carrying ...
Feb 15, 2013
5 / 5 (1)
0
|
Red coloration—historically seen as costly in vertebrates—historically seen as costly in vertebrates—might represent some physiological benefit after all, according to research published in the journal Physiological an ...
Jan 28, 2013
3 / 5 (5)
6
|
(Phys.org)—New insights by WAIMR researchers into how a tiny microRNA molecule may suppress prostate tumours have been published internationally, in the Journal of Biological Chemistry.
Jan 16, 2013
5 / 5 (4)
0
Mice with black fur that turns white? Specialist cancer researchers from Inserm, CNRS, the Institut Curie and the Université Paris-Sud have taken steps to better understand the development of skin cells responsible for pigmentation ...
Oct 05, 2012
not rated yet
0
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.
Jun 13, 2011
5 / 5 (5)
1
|
Researchers at the University of Pennsylvania School of Medicine may have found a way to turn an adaptive cellular response into a liability for cancer cells. When normal cells are starved for food, they chew up existing ...
Apr 05, 2011
4 / 5 (1)
1
Alpha viruses, such as Sindbis virus, carry their genetic information on a single strand of RNA. On infection they use a protein, replicase, to produce double stranded RNA (dsRNA) which is used as genetic material to make ...
Mar 28, 2011
not rated yet
0
The U.S. Food and Drug Administration today approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. It is the first drug approved for metastatic, or advanced, melanoma is more than a decade.
Mar 25, 2011
not rated yet
0
(AP) -- The Food and Drug Administration has approved a breakthrough cancer medication from Bristol-Myers Squibb Co. that researchers have heralded as the first drug to prolong the lives of patients with ...
Mar 25, 2011
4.3 / 5 (4)
1
Researchers at Boston University School of Medicine (BUSM), in collaboration with Johns Hopkins University, have identified a potential new biomarker and therapeutic target for melanoma. The novel cell screening method used ...
Mar 17, 2011
not rated yet
0
Researchers at UCLA's Jules Stein Eye Institute have created new tumor cell lines from fine-needle biopsies of ocular melanoma patients who had undergone treatment but died when their cancer spread aggressively.
Mar 11, 2011
not rated yet
0
Manipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body's own immune cells to fight such diseases as metastatic melanoma, non-Hodgkin's ...
Mar 02, 2011
not rated yet
0
|
